Drugs /
pneumococcal 13-valent conjugate vaccine
Overview
Pneumococcal 13-valent conjugate vaccine has been investigated in 3 clinical trials, of which 3 are open and 0 are closed. Of the trials investigating pneumococcal 13-valent conjugate vaccine, 1 is early phase 1 (1 open), 1 is phase 1/phase 2 (1 open), and 1 is phase 2 (1 open).
Diffuse large B-cell lymphoma, hepatocellular carcinoma, and high grade B-cell lymphoma, not otherwise specified are the most common diseases being investigated in pneumococcal 13-valent conjugate vaccine clinical trials [2].
Drug Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.